# Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer

> **NCT00070057** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 75 (actual)

## Conditions studied

- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer

## Interventions

- **DRUG:** celecoxib
- **PROCEDURE:** therapeutic conventional surgery
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00070057
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070057, "Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00070057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*